Prioritizing Genes Related to Myasthenia Gravis and Estrogen
Author Information
Author(s): Kaur Mandeep, Schmeier Sebastian, MacPherson Cameron R, Hofmann Oliver, Hide Winston A, Taylor Stephen, Willcox Nick, Bajic Vladimir B
Primary Institution: South African National Bioinformatics Institute, University of the Western Cape
Hypothesis
Can we prioritize genes associated with myasthenia gravis that are potentially influenced by sex hormones?
Conclusion
The developed method successfully prioritizes genes relevant to myasthenia gravis and estrogen control, outperforming existing methods.
Supporting Evidence
- The method identified 90% of known myasthenia gravis-associated genes from the analyzed region.
- Top ranked genes include HLA-G and TUBB as new candidates for further study.
- The method outperformed existing gene prioritization methods for myasthenia gravis.
Takeaway
The researchers created a new way to find important genes for a disease called myasthenia gravis that might be affected by hormones like estrogen.
Methodology
A computational method was developed to prioritize genes based on their responsiveness to estrogen and relevance to myasthenia gravis, using various gene information and scoring.
Potential Biases
The method may not account for all potential estrogen-responsive genes outside the studied region.
Limitations
The study is limited to one specific region of chromosome 6, and other genes outside this region may also be involved in myasthenia gravis.
Participant Demographics
The study focuses on genes related to early-onset myasthenia gravis, which shows a 3:1 female bias.
Statistical Information
P-Value
9.99 × 10-13
Statistical Significance
p<0.05
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website